Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...
Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.
The trail enrolled 123 patients at 23 sites across the US and Europe.
Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for pulmonary embolectomy.
Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...
Even after a blood clot is removed from a large artery in the brain via a minimally invasive procedure to treat a clot-caused stroke, delivering the clot-busting medication alteplase to the area may ...
Two-pronged treatment approach may increase the number of people who fully recover from stroke due to a blockage in a large brain artery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results